EU Sounds Alarm On Critical Lithium Shortage
The EU needs 18X more lithium for neutrality in 2030- and this one company may solve the shortage.

NYSE:CTVA - Corteva Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $43.19
  • Forecasted Upside: -8.03 %
  • Number of Analysts: 21
  • Breakdown:
  • 3 Sell Ratings
  • 6 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$46.96
▼ -0.56 (-1.18%)
1 month | 3 months | 12 months
Get New Corteva Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTVA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$43.19
▼ -8.03% Downside Potential
This price target is based on 21 analysts offering 12 month price targets for Corteva in the last 3 months. The average price target is $43.19, with a high forecast of $54.00 and a low forecast of $28.00. The average price target represents a -8.03% upside from the last price of $46.96.
The #1 Way to Play the CBD Sector
A proprietary product line, unmatched distribution formula, and exponential growth potential in an explosive industry makes this company the top way to play the legal cannabis sector
Hold
The current consensus among 21 investment analysts is to hold stock in Corteva. This rating has held steady since January 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 7 hold ratings
  • 2 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 2 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 3 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 6 hold ratings
  • 3 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 3 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 3 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/19/2021KeyCorpBoost Price TargetOverweight$51.00 ➝ $53.00Low
i
4/19/2021Loop CapitalUpgradeHold ➝ Buy$54.00Low
i
4/12/2021KeyCorpBoost Price TargetOverweight$51.00 ➝ $53.00Low
i
2/5/2021Credit Suisse GroupBoost Price TargetNeutral$39.00 ➝ $42.00Low
i
2/5/2021Morgan StanleyBoost Price TargetOverweight$46.00 ➝ $50.00Medium
i
2/5/2021Monness Crespi & HardtBoost Price TargetSell$24.00 ➝ $32.00High
i
2/5/2021KeyCorpBoost Price TargetOverweight$49.00 ➝ $51.00High
i
2/5/2021Royal Bank of CanadaBoost Price TargetOutperform$45.00 ➝ $52.00Medium
i
2/5/2021BarclaysBoost Price TargetEqual Weight$37.00 ➝ $46.00Medium
i
2/5/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$32.00 ➝ $51.00Medium
i
2/4/2021UBS GroupBoost Price TargetBuy$44.00 ➝ $48.00Low
i
1/21/2021Redburn PartnersDowngradeBuy ➝ NeutralHigh
i
1/15/2021KeyCorpBoost Price TargetOverweight$40.00 ➝ $49.00Low
i
1/8/2021Deutsche Bank AktiengesellschaftBoost Price TargetOutperform ➝ Buy$40.00 ➝ $50.00High
i
12/18/2020Susquehanna BancsharesDowngradePositive ➝ NeutralHigh
i
12/14/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$35.00 ➝ $46.00Low
i
11/16/2020Royal Bank of CanadaBoost Price Target$37.00 ➝ $39.00Low
i
11/10/2020ArgusUpgradeHold ➝ Buy$42.00High
i
11/9/2020Morgan StanleyBoost Price TargetEqual Weight$29.00 ➝ $35.00Low
i
11/9/2020KeyCorpBoost Price TargetOverweight$36.00 ➝ $40.00Low
i
11/6/2020Deutsche Bank AktiengesellschaftBoost Price Target$32.00 ➝ $40.00Low
i
11/6/2020Credit Suisse GroupBoost Price TargetNeutral$28.00 ➝ $34.00Low
i
11/6/2020BMO Capital MarketsBoost Price TargetOutperform$36.00 ➝ $38.00Low
i
10/19/2020Exane BNP ParibasDowngradeOutperform ➝ UnderperformLow
i
10/19/2020Bank of AmericaUpgradeNeutral ➝ Buy$40.00High
i
10/19/2020BNP ParibasDowngradeOutperform ➝ UnderperformHigh
i
10/7/2020KeyCorpBoost Price TargetOverweight$31.00 ➝ $36.00Medium
i
8/18/2020Loop CapitalLower Price TargetHold$32.00 ➝ $30.00Medium
i
8/11/2020KeyCorpUpgradeSector Weight ➝ Overweight$31.00High
i
8/10/2020Bank of AmericaDowngradeBuy ➝ Neutral$32.00 ➝ $28.00Low
i
Rating by Steve Byrne at Bank of America Co.
8/7/2020Credit Suisse GroupLower Price TargetNeutral$31.00 ➝ $28.00Low
i
7/13/2020Bank of AmericaUpgradeUnderperform ➝ BuyHigh
i
Rating by Steve Byrne at Bank of America Co.
6/26/2020Cleveland ResearchInitiated CoverageNeutralLow
i
6/16/2020Vertical ResearchUpgradeHold ➝ Buy$31.00Medium
i
Rating by Kevin McCarthy at Vertical Research
6/8/2020Monness Crespi & HardtDowngradeNeutral ➝ Sell$24.00High
i
Rating by Christopher Shaw at Monness Crespi & Hardt
6/2/2020Morgan StanleyBoost Price TargetEqual Weight$27.00 ➝ $29.00High
i
5/11/2020BarclaysLower Price TargetEqual Weight$32.00 ➝ $30.00High
i
5/11/2020Royal Bank of CanadaBoost Price TargetOutperform$27.00 ➝ $31.00High
i
5/11/2020Bank of AmericaDowngradeNeutral ➝ UnderperformHigh
i
Rating by Steve Byrne at Bank of America Co.
5/8/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$34.00 ➝ $32.00Low
i
5/8/2020CitigroupBoost Price TargetBuy$32.00 ➝ $34.00High
i
5/5/2020CSFBLower Price TargetNeutral$31.00 ➝ $28.00Low
i
5/5/2020Credit Suisse GroupLower Price TargetNeutral$31.00 ➝ $28.00Medium
i
4/17/2020Bank of AmericaDowngradeBuy ➝ NeutralMedium
i
Rating by Steve Byrne at Bank of America Co.
4/17/2020Loop CapitalUpgradeSell ➝ Hold$28.00Medium
i
Rating by Chris Kapsch at Loop Capital
4/1/2020BNP ParibasUpgradeNeutral ➝ OutperformHigh
i
3/31/2020Susquehanna BancsharesUpgradeNeutral ➝ Positive$34.00 ➝ $29.00High
i
Rating by Don Carson at Susquehanna Bancshares, Inc.
3/30/2020Morgan StanleyLower Price TargetEqual Weight$30.00 ➝ $27.00Low
i
3/25/2020KeyCorpInitiated CoverageSector Weight ➝ Sector WeightHigh
i
3/18/2020Edward JonesUpgradeHold ➝ BuyHigh
i
3/13/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
3/10/2020Monness Crespi & HardtUpgradeSell ➝ NeutralHigh
i
2/4/2020Susquehanna BancsharesDowngradePositive ➝ Neutral$36.00 ➝ $34.00High
i
Rating by Don Carson at Susquehanna Bancshares, Inc.
2/2/2020Credit Suisse GroupReiterated RatingHold$31.00High
i
1/31/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$26.00 ➝ $29.00Medium
i
1/23/2020Bernstein BankUpgradeOutperform$39.00Low
i
1/23/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$39.00Low
i
1/23/2020Loop CapitalDowngradeHold ➝ Sell$23.00Low
i
1/17/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$27.00 ➝ $26.00Medium
i
12/19/2019Vertical ResearchInitiated CoverageHold$27.00Low
i
12/19/2019UBS GroupLower Price TargetBuy$33.00 ➝ $32.00Medium
i
11/12/2019Redburn PartnersInitiated CoverageBuyHigh
i
11/1/2019BarclaysSet Price TargetHold$32.00N/A
i
Rating by Duffy Fischer at Barclays PLC
11/1/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$30.00 ➝ $27.00Medium
i
10/11/2019SunTrust BanksLower Price TargetHold$30.00 ➝ $28.00Low
i
10/9/2019CitigroupLower Price TargetBuy$34.50 ➝ $31.00Low
i
8/19/2019CitigroupUpgradeNeutral ➝ Buy$34.00 ➝ $34.50Low
i
8/9/2019Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$29.00 ➝ $38.00Low
i
8/4/2019BarclaysReiterated RatingHold$35.00High
i
8/2/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$32.00 ➝ $35.00Low
i
7/17/2019Monness Crespi & HardtInitiated CoverageSell ➝ Sell$24.00High
i
7/1/2019Loop CapitalInitiated CoverageHold ➝ Hold$31.00Medium
i
7/1/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$32.00Low
i
6/21/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$30.00Low
i
6/20/2019ArgusInitiated CoverageHold ➝ HoldLow
i
6/20/2019Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$29.00Low
i
6/16/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$30.00 ➝ $32.00High
i
6/10/2019Nomura SecuritiesInitiated CoverageNeutral$28.00Low
i
6/5/2019Sanford C. BernsteinInitiated CoverageMkt Perform ➝ Market Perform$31.00High
i
6/4/2019MacquarieInitiated CoverageOutperform ➝ OutperformMedium
i
6/4/2019UBS GroupInitiated CoverageBuy ➝ Buy$38.00High
i
6/3/2019CitigroupInitiated CoverageNeutral$29.00N/A
i
6/3/2019SunTrust BanksInitiated CoverageHold ➝ Hold$29.00N/A
i
6/3/2019Morgan StanleyInitiated CoverageEqual Weight ➝ Equal Weight$32.00N/A
i
6/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHoldN/A
i
6/3/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$29.00N/A
i
6/2/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$37.00N/A
i
5/29/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyN/A
i
(Data available from 4/21/2016 forward)
Corteva logo
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $46.96
$46.66
$47.83

50 Day Range

MA: $46.70
$43.85
$47.91

52 Week Range

Now: $46.96
$22.38
$48.48

Volume

2,415,577 shs

Average Volume

3,389,522 shs

Market Capitalization

$34.78 billion

P/E Ratio

57.27

Dividend Yield

1.09%

Beta

0.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Corteva?

The following Wall Street research analysts have issued research reports on Corteva in the last twelve months: Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, BNP Paribas, Citigroup Inc., Cleveland Research, Credit Suisse Group AG, CSFB, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, JPMorgan Chase & Co., KeyCorp, Loop Capital, Monness Crespi & Hardt, Morgan Stanley, Redburn Partners, Royal Bank of Canada, Susquehanna Bancshares, Inc., UBS Group AG, Vertical Research, and Zacks Investment Research.
View the latest analyst ratings for CTVA.

What is the current price target for Corteva?

16 Wall Street analysts have set twelve-month price targets for Corteva in the last year. Their average twelve-month price target is $43.19, suggesting a possible downside of 8.0%. Loop Capital has the highest price target set, predicting CTVA will reach $54.00 in the next twelve months. CSFB has the lowest price target set, forecasting a price of $28.00 for Corteva in the next year.
View the latest price targets for CTVA.

What is the current consensus analyst rating for Corteva?

Corteva currently has 3 sell ratings, 6 hold ratings and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CTVA, but not buy more shares or sell existing shares.
View the latest ratings for CTVA.

What other companies compete with Corteva?

How do I contact Corteva's investor relations team?

Corteva's physical mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company's listed phone number is 302-485-3000. The official website for Corteva is www.corteva.com.

The #1 Way to Play the CBD Sector
A proprietary product line, unmatched distribution formula, and exponential growth potential in an explosive industry makes this company the top way to play the legal cannabis sector